Get my own profile
Public access
View all57 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Donald L. GillPenn State University College of MedicineVerified email at psu.edu
- Madesh MuniswamyProfessor, UT Health, San AntonioVerified email at uthscsa.edu
- Robert HooperRockland ImmunochemicalsVerified email at temple.edu
- salvatore mancarellaVerified email at uthsc.edu
- Michael Ritchiechampions oncologyVerified email at championsoncology.com
- yandong zhouPenn State University College of MedicineVerified email at psu.edu
- Wang YoujunBeijing Normal UniversityVerified email at bnu.edu.cn
- Harry C. BlairProfessor of Pathology, University of PittsburghVerified email at pitt.edu
- Brad S. RothbergProfessor of Medical Genetics & Molecular Biochemistry, Temple University School of MedicineVerified email at temple.edu
- Lisa J. RobinsonModulation TherapeuticsVerified email at modulationtherapeutics.com
- Reinhold Penner, MD PhDDirector of Research, The Queen's Medical CenterVerified email at hawaii.edu
- Prof. Suhel ParvezProfessor, Department of Toxicology, School of Chemical and Life SciencesVerified email at jamiahamdard.ac.in
- M. Raza ZaidiFels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine at Temple UniversityVerified email at temple.edu
- Brij B SinghProfessor, University of Texas Health Science Center San Antonio TXVerified email at uthscsa.edu
- Sonal SrikanthAdjunct Associate Professor, UCLAVerified email at mednet.ucla.edu
- Kwong Tai ChengNational Institutes of HealthVerified email at nidcr.nih.gov
- Bidhan BandyopadhyayPrincipal Investigator, DC VA Medical CenterVerified email at va.gov
- Yousang GwackUniversity of California Los AngelesVerified email at mednet.ucla.edu
- Biswaranjan PaniDuke University Medical CenterVerified email at receptor-biol.duke.edu
- Chanyu YueSenior Scientist, Vividion TherapeuticsVerified email at vividion.com